Fibroblasts in Diabetic Foot Ulcers
International Journal of Molecular Sciences · 11.02.2024 · 25 (4) · 2172
DOI: 10.3390/ijms25042172 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.02.2024. Verfasst von Francesca A Voza und 9 weiteren Autor:innen. Beteiligte Einrichtung: DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Diabetic Foot, Diabetes Mellitus. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Fibroblasts are stromal cells ubiquitously distributed in the body of nearly every organ tissue. These cells were previously considered to be “passive cells”, solely responsible for ensuring the turnover of the extracellular matrix (ECM). However, their versatility, including their ability to switch phenotypes in response to tissue injury and dynamic activity in the maintenance of tissue specific homeostasis and integrity have been recently revealed by the innovation of technological tools such as genetically modified mouse models and single cell analysis. These highly plastic and heterogeneous cells equipped with multifaceted functions including the regulation of angiogenesis, inflammation as well as their innate stemness characteristics, play a central role in the delicately regulated process of wound healing. Fibroblast dysregulation underlies many chronic conditions, including cardiovascular diseases, cancer, inflammatory diseases, and diabetes mellitus (DM), which represent the current major causes of morbidity and mortality worldwide. Diabetic foot ulcer (DFU), one of the most severe complications of DM affects 40 to 60 million people. Chronic non-healing DFU wounds expose patients to substantial sequelae including infections, gangrene, amputation, and death. A complete understanding of the pathophysiology of DFU and targeting pathways involved in the dysregulation of fibroblasts are required for the development of innovative new therapeutic treatments, critically needed for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Vascular Biology Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Department of Biochemistry & Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Department of Internal Medicine, Division of Pulmonary Critical Care & Sleep Medicine, University of Florida, Gainesville, FL 32611, USA.
ORCID-Profile: Francesca A Voza, Carlos Theodore Huerta
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Voza, F. A., Huerta, C. T., Le, N., Shao, H., Ribieras, A., Ortiz, Y., Atkinson, C., Machuca, T., Liu, Z. J., & Velazquez, O. C. (2024). Fibroblasts in Diabetic Foot Ulcers. International Journal of Molecular Sciences, 25(4), 2172. https://doi.org/10.3390/ijms25042172
Vancouver
Voza FA, Huerta CT, Le N, Shao H, Ribieras A, Ortiz Y, et al. Fibroblasts in Diabetic Foot Ulcers. International Journal of Molecular Sciences. 2024;25(4):2172. doi:10.3390/ijms25042172
BibTeX
@article{Voza2024,
author = {Voza, Francesca A and Huerta, Carlos Theodore and Le, Nga and Shao, Hongwei and Ribieras, Antoine and Ortiz, Yulexi and Atkinson, Carl and Machuca, Tiago and Liu, Zhao-Jun and Velazquez, Omaida C},
title = {Fibroblasts in Diabetic Foot Ulcers},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {4},
pages = {2172},
doi = {10.3390/ijms25042172}
}
EUVIMED